Announcements Trials
Browse Landscape

Status

Completed 208Recruiting 58Terminated 57Unknown 38Withdrawn 24Active not recruiting 15Not yet recruiting 9Suspended 4Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 73Breast Neoplasms 73Colorectal Neoplasms 39Prostatic Neoplasms 37Carcinoma, Non-Small-Cell Lung 27Lung Neoplasms 26Uterine Cervical Neoplasms 20Stomach Neoplasms 20Carcinoma, Hepatocellular 20Pancreatic Neoplasms 15Anxiety Disorders 15Leukemia, Myeloid, Acute 14Hematologic Neoplasms 13Colonic Neoplasms 13Urinary Bladder Neoplasms 12Lymphoma, Follicular 12Brain Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Head and Neck Neoplasms 10Esophageal Neoplasms 10Diabetes Mellitus 10Sarcoma 9Ovarian Neoplasms 9Melanoma 9Liver Neoplasms 9Esophageal Squamous Cell Carcinoma 9Rectal Neoplasms 8Pulmonary Disease, Chronic Obstructive 8Epilepsy 8Disease 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Clear all
NCT05509855 2024-11-20

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

Wugen, Inc.

Enrolling by invitation
44 enrolled
LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡